The Food and Drug Administration approved a groundbreaking new oral drug for pancreatic patients suffering from the most aggressive form of the disease. Daraxonrasib, which targets a mutation in a gene called KRAS, doubled the survival time in patients who participated in the trial.
Nbc News
Original source
The autoimmune brain and spinal cord disease shares symptoms with MS, making it difficult to identify.
After establishing breast care services at Singapore General Hospital in 1992, Nagalingam Saraswathi trained nurses from other hospitals and started a support group for breast cancer patients. More than three decades later, caring for them remains a huge part of her life.
A female patient is in isolation and receiving medical care after being admitted to a hospital in Abuja.
Officials say alternatives for the unavailable brand remain available in local markets.
Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer